EFFICACY ApSActive

CVR 35862129Founded 2014

Key figures

2.282.051 kr.+39,9%
Gross profit 2025/26
+39,9%
Average annual growth 2024/25–2025/26
01 m2 m3 m2024/252025/26

Key ratios

2025/26
Balance sheet structure
Current assetsNon-current assetsLiabilities and provisionsEquity
0500 k1 m2024/252025/26

Dividends

from the annual report
2025/26

Proposed dividend for the financial year 397.633 kr. (100% of the profit for the year).

History
2025/26397.633 kr.
2024/25315.966 kr.

Proposed dividend from the annual report's profit allocation (normally paid the following year). If there is no proposal, the dividend paid according to the statement of changes in equity is shown.

Financial statements2025–2026
2024/252025/26
Balance sheet — assets
Cash and cash equivalents286.689557.272
Total current assets960.034949.313
Total non-current assets——
Total assets960.034949.313
Balance sheet — liabilities and equity
Current liabilities519.068426.681
Non-current liabilities——
Total liabilities519.068426.681
Share capital125.000125.000
Retained earnings of previous periods0-1
Profit for the year315.966397.632
Total equity440.966522.632
Income statement
Gross profit1.631.6652.282.051
Operating profit405.287512.743
EBITDA423.712512.743
Profit before income tax406.615512.730
Profit for the reporting year315.966397.632
Labour costs1.207.9531.769.308
Depreciation of non-current assets18.4250
Other indicators
Employees12
Dividends315.966397.633

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

About the company

Annual report 2026

Selskabets aktivitet har i lighed med tidligere år bestået af at udøve virksomhed med køb og salg af konsulenttjenester og dertil naturligt beslægtede produkter og tjenesteydelser.

Der har ikke været væsentlige ændringer i aktiviteter og økonomiske forhold. Årets bruttofortjeneste udgør 2.282.051 kr. mod 1.631.665 kr. sidste år. Det ordinære resultat efter skat udgør 397.632 kr. mod 315.966 kr. sidste år. Ledelsen anser årets resultat for tilfredsstillende.

Excerpt from the management's review in the latest annual report.

EFFICACY ApS — cvrprofil.dk